Soluble CX3CL1 gene therapy improves cone survival and function in mouse models of retinitis pigmentosa

被引:0
|
作者
Wang, Sean K. [1 ]
Xue, Yunlu [1 ]
Rana, Parimal [1 ]
Hong, Christin [1 ]
Cepko, Constance [1 ]
机构
[1] Harvard Med Sch, Genet, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
5175
引用
收藏
页数:3
相关论文
共 50 条
  • [41] C1q enhances cone photoreceptor survival in a mouse model of autosomal recessive retinitis pigmentosa
    Humphries, Marian M.
    Kenna, Paul F.
    Campbell, Matthew
    Tam, Lawrence C. S.
    Nguyen, Anh T. H.
    Farrar, G. Jane
    Botto, Marina
    Kiang, Anna Sophia
    Humphries, Peter
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2012, 20 (01) : 64 - 68
  • [42] Respiratory syncytial virus glycoprotein G impedes CX3CR1-activation by CX3CL1 and monocyte function
    Robert Meineke
    Ayse Agac
    Marie-Christin Knittler
    Martin Ludlow
    Albert D. M. E. Osterhaus
    Guus F. Rimmelzwaan
    npj Viruses, 2 (1):
  • [43] Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX3CL1/CX3CR1 Pathway in Experimental Mouse Models of Systemic Sclerosis
    Luong, Vu H.
    Utsunomiya, Akira
    Chino, Takenao
    Doanh, Le H.
    Matsushita, Takashi
    Obara, Takashi
    Kuboi, Yoshikazu
    Ishii, Naoto
    Machinaga, Akihito
    Ogasawara, Hideaki
    Ikeda, Wataru
    Kawano, Tetsu
    Imai, Toshio
    Oyama, Noritaka
    Hasegawa, Minoru
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (11) : 1923 - 1934
  • [44] CX3CL1 (Fractalkine) Protein Expression in Normal and Degenerating Mouse Retina: In Vivo Studies
    Zieger, Marina
    Ahnelt, Peter K.
    Uhrin, Pavel
    PLOS ONE, 2014, 9 (09):
  • [45] Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis
    Matsunawa, Mizuho
    Isozaki, Takeo
    Odai, Tsuyoshi
    Yajima, Nobuyuki
    Takeuchi, Hiroko T.
    Negishi, Masao
    Ide, Hirotsugu
    Adachi, Mitsuru
    Kasama, Tsuyoshi
    ARTHRITIS AND RHEUMATISM, 2006, 54 (11): : 3408 - 3416
  • [46] Inhibition of fractalkine (CX3CL1) improves experimental autoimmune myositis in SJL/J mice.
    Suzuki, F
    Nanki, T
    Imai, T
    Kikuchi, H
    Hirohata, S
    Kohsaka, H
    Miyasaka, N
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S470 - S470
  • [47] Increased expression of soluble fractalkine (CX3CL1) in systemic sclerosis - possible role in vascular inflammation
    El-Sergany, Mervat
    Shahba, Abeer
    Ghazy, Medhat
    Bedewy, Mohammed M.
    Bahr, Hoda
    Hassan, Azza M.
    Attia, Mohammed
    EGYPTIAN RHEUMATOLOGIST, 2011, 33 (02): : 93 - 98
  • [48] Gene Therapy Successfully Restores Retinal Function and Delays Degeneration in a Mouse Model of CNGB1-linked Retinitis Pigmentosa
    Zobel, Lena
    Wagner, Johanna E.
    O'Riordan, Catherine R.
    Frederick, Amy M.
    Biel, Martin
    Michalakis, Stylianos
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [49] CX3CL1/fractalkine is a novel regulator of normal and malignant human B cell function
    Corcione, Anna
    Ferretti, Elisa
    Pistoia, Vito
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 92 (01) : 51 - 58
  • [50] Insulin resistance aggravates atherosclerosis by reducing vascular smoothmuscle cell survival and increasing CX3CL1/CX3CR1 axis
    Martinez-Hervas, Sergio
    Vinue, Angela
    Nunez, Laura
    Andres-Blasco, Irene
    Piqueras, Laura
    Tomas Real, Jose
    Francisco Ascaso, Juan
    Jane Burks, Deborah
    Jesus Sanz, Maria
    Gonzalez-Navarro, Herminia
    CARDIOVASCULAR RESEARCH, 2014, 103 (02) : 324 - 336